Qube Research & Technologies LTD Glaukos Corp Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Glaukos Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 52,411 shares of GKOS stock, worth $6.33 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
52,411
Previous 86,533
39.43%
Holding current value
$6.33 Million
Previous $6.88 Million
28.16%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding GKOS
# of Institutions
279Shares Held
43.7MCall Options Held
89.8KPut Options Held
236K-
Black Rock Inc. New York, NY7.9MShares$953 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.31MShares$641 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.13MShares$257 Million3.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$220 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.61MShares$194 Million0.09% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.75B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...